HomeNewsBusinessDelay in imports from China may impact production in India: Dixon's Atul Lall

Delay in imports from China may impact production in India: Dixon's Atul Lall

Electronics and auto companies may reduce output from April 2022 as the supply of parts to India from China could be delayed by 10-15 days

March 22, 2022 / 10:53 IST
Story continues below Advertisement
In Shanghai, residents are staying indoors amid a surge in cases across China.
In Shanghai, residents are staying indoors amid a surge in cases across China.

As China scrambles to contain the country’s worst outbreak of COVID-19 since early 2020, mobility restrictions have added to the chaos in the global supply chain. China has imposed stay-at-home orders on millions and slapped lockdowns in several parts of the country, which could impact production in India.

"There is a delay of a week in imports from Shenzen and the delay of imports could impact production here in April," said Atul Lall, Managing Director (MD), Dixon Technologies in an exclusive interview with CNBC TV-18.

Story continues below Advertisement

Also Read: Dixon Technologies: Growth holds up, margin feels the heat

Electronics and auto companies may reduce output from April 2022  as supply of parts to India from China could be delayed by 10-15 days.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show